Veradigm CEO Transition Underway Amid Optimistic Financial Outlook
Until a new CEO is identified, three principal executives are jointly managing CEO responsibilities at the company
Read More
Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia
The ability to harness real-world insights at scale empowers life sciences companies and clinicians to develop more targeted therapies, improve patient outcomes, and drive evidence-based innovation in BPH treatment. The post Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia appeared first on MedCity News.
Estados apuntan a los alimentos ultraprocesados con iniciativas bipartidistas
James Gallagher, republicano de California y ex líder de la bancada del Partido Republicano en la Asamblea estatal, ha acusado con frecuencia a los legisladores progresistas del estado de intervenir demasiado en las cuestiones de gobierno. Sin embargo, este año sumó su nombre a una iniciativa legislativa para que las comidas escolares sean más saludables….
GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years
President Trump has been pursuing policies intended to entice drugmakers to bring manufacturing and jobs to the U.S. GSK’s announcement makes it the latest big pharma company to unveil a multi-billion dollar plan for new U.S. facilities. The post GSK Plans to Spend $30B on U.S. Manufacturing and R&D Infrastructure Over the Next 5 Years…
How Much More Would People Pay in Premiums if the ACA’s Enhanced Subsidies Expired
Enhanced Affordable Care Act (ACA) subsidies lower premium payments for ACA Marketplace coverage by boosting existing ACA subsidies and making some people newly eligible. Enrollees across incomes benefit from these subsidies. For example, low-income enrollees (making up to 150% of the poverty level) became eligible for free or nearly free coverage. Those earning over four…More
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
The conditions the biopharma companies target include sepsis, antimicrobial resistance, and acute infectious conjunctivitis. The post Which Biopharma Startups Made the Cut for INVEST Pitch Perfect? appeared first on MedCity News.
Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs
July has seen a slew of executive hires, exits and layoffs across the healthcare sector. For example, Aledade and Teladoc Health welcomed new executives, and DexCom and Community Health Systems announced that their CEOs are departing. There were also layoffs at organizations including Best Buy Health, the VA and Sarepta Therapeutics. The post Healthcare Moves:…
After Wegovy’s Historic MASH Approval, What’s Next?
Approval is only the beginning. Now comes the harder part: identifying the right patients, detecting the disease earlier, and monitoring outcomes so that this promising treatment is effective at scale. The post After Wegovy’s Historic MASH Approval, What’s Next? appeared first on MedCity News.
Is Payers’ Provider Data “Clean, Complete, and Centralized” or is There a Crisis of Overconfidence?
[Sponsored] In this whitepaper, ProviderTrust outlines the overwhelmingly positive survey results and compares them to our experiences getting up close and personal with the provider data in question. The post Is Payers’ Provider Data “Clean, Complete, and Centralized” or is There a Crisis of Overconfidence? appeared first on MedCity News.
KFF Health News’ ‘What the Health?’: The Campaign’s Final Days
The Host Emmarie Huetteman KFF Health News Emmarie Huetteman, senior editor, oversees a team of Washington reporters, as well as “Bill of the Month” and KFF Health News’ “What the Health?” She previously spent more than a decade reporting on the federal government, most recently covering surprise medical bills, drug pricing reform, and other health policy debates…